A carregar...

An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer

BACKGROUND: Combining anti-cancer therapies with orthogonal modes of action, such as direct cytotoxicity and immunostimulatory, hold promise for expanding clinical benefit to patients with metastatic disease. For instance, a chemotherapy agent Oxaliplatin (OXP) in combination with Interleukin-12 (IL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Wang, Qing, Wang, Zhijun, Wu, Yan, Klinke, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6950805/
https://ncbi.nlm.nih.gov/pubmed/31914948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6500-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!